Authors:
Tweedy, CM
Milgrom, P
Kharasch, ED
Kaakko, T
Spieker, M
Coldwell, SE
Citation: Cm. Tweedy et al., Pharmacokinetics and clinical effects of sublingual triazolam in pediatricdental patients, J CL PSYCH, 21(3), 2001, pp. 268-272
Citation: Y. Oda et Ed. Kharasch, Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): Potential contribution of intestinal metabolism to presysternic clearance and bioactivation, J PHARM EXP, 298(3), 2001, pp. 1021-1032
Citation: Y. Oda et Ed. Kharasch, Metabolism of levo-alpha-acetylmethadol (LAAM) by human liver cytochrome P450: Involvement of CYP3A4 characterized by atypical kinetics with two binding sites, J PHARM EXP, 297(1), 2001, pp. 410-422
Authors:
Yao, CP
Kunze, KL
Kharasch, ED
Wang, Y
Trager, WF
Ragueneau, I
Levy, RH
Citation: Cp. Yao et al., Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2, CLIN PHARM, 70(5), 2001, pp. 415-424
Citation: Ae. Ibrahim et al., Bispectral Index Monitoring during Sedation with Sevoflurane, Midazolam, and Propofol, ANESTHESIOL, 95(5), 2001, pp. 1151-1159
Citation: Y. Minoda et Ed. Kharasch, Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6), ANESTHESIOL, 95(2), 2001, pp. 509-514
Authors:
Ibrahim, AE
Ghoneim, MM
Kharasch, ED
Epstein, RH
Groudine, SB
Ebert, TJ
Binstock, WB
Philip, BK
Citation: Ae. Ibrahim et al., Speed of recovery and side-effect profile of sevoflurane sedation comparedwith midazolam, ANESTHESIOL, 94(1), 2001, pp. 87-94
Authors:
Kharasch, ED
Frink, EJ
Artru, A
Michalowski, P
Rooke, GA
Nogami, W
Citation: Ed. Kharasch et al., Long-duration low-flow sevoflurane and lsoflurane effects on postoperativerenal and hepatic function, ANESTH ANAL, 93(6), 2001, pp. 1511-1520
Authors:
Kharasch, ED
Hankins, DC
Fenstamaker, K
Cox, K
Citation: Ed. Kharasch et al., Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4, EUR J CL PH, 55(11-12), 2000, pp. 853-859
Citation: Ed. Kharasch et C. Jubert, Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia - Biomarkers for exposure, risk assessment, and interspecies comparison (vol 91, pg 1267, 1999), ANESTHESIOL, 92(1), 2000, pp. 297-297
Authors:
Davis, CL
Kausz, AT
Zager, RA
Kharasch, ED
Cochran, RP
Citation: Cl. Davis et al., Acute renal failure after cardiopulmonary bypass is related to decreased serum ferritin levels, J AM S NEPH, 10(11), 1999, pp. 2396-2402
Authors:
Groudine, SB
Fragen, RJ
Kharasch, ED
Eisenman, TS
Frink, EJ
McConnell, S
Citation: Sb. Groudine et al., Comparison of renal function following anesthesia with low-flow sevoflurane and isoflurane, J CLIN ANES, 11(3), 1999, pp. 201-207
Authors:
Kharasch, ED
Jubert, C
Senn, T
Bowdle, TA
Thummel, KE
Citation: Ed. Kharasch et al., Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearance, J CLIN PHAR, 39(7), 1999, pp. 664-669
Authors:
Kharasch, ED
Hankins, DC
Jubert, C
Thummel, KE
Taraday, JK
Citation: Ed. Kharasch et al., Lack of single-dose disulfiram effects on cytochrome P-4502C9, 2C19, 2D6, and 3A4 activities: Evidence for specificity toward P-450 2E1, DRUG META D, 27(6), 1999, pp. 717-723
Authors:
Kharasch, ED
Jubert, C
Spracklin, DK
Hoffman, GM
Citation: Ed. Kharasch et al., Dose-dependent metabolism of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (Compound A), an anesthetic degradation product, to mercapturicacids and 3,3,3-trifluoro-2(fluoromethoxy)propanoic acid in rats, TOX APPL PH, 160(1), 1999, pp. 49-59
Citation: Ed. Kharasch et D. Hankins, Renal cysteine conjugate beta-lyase and compound A nephrotoxicity: Minimalevidence for an association - Reply, ANESTHESIOL, 90(3), 1999, pp. 921-922